Clinical Trials Browser

OTHER × OKN 007 × Clear all

NCT03587038 2025-12-10

OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma

Phase 1 Active not recruiting

Glioblastoma